SCHEMBL6679211

SCHEMBL6679211

NC(=O)OC(Cc1ccccn1)c1ccc(N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRA P18433 1/20 0.46
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2A Q12879 1/20 0.43
GRIN2B Q13224 1/20 0.43
GRIN2C Q14957 1/20 0.43
GRIN3A Q8TCU5 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
FDPS P14324 1/20 0.42
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
PARP10 Q53GL7 1/20 0.41
PGR P06401 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
PTGS1 P23219 1/20 0.41
SLC6A2 P23975 1/20 0.41
PRMT1 Q99873 1/20 0.40
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6682451 0.84 KMT2A (0.47) PTPRAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6683519 0.82 L3MBTL1 (0.40) PTPRAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6683073 0.77 SLC6A3 (0.39) SLC6A2SYK
SCHEMBL27608757 0.77 SOAT1 (0.51) NPC1SMN1; SMN2
SCHEMBL29096870 0.74 PTPRA (0.50) PTPRAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL29096871 0.74 PTPRA (0.50) PTPRAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6682504 0.73 SLC6A3 (0.40) NPC1SMN1; SMN2
SCHEMBL6794994 0.70 L3MBTL1 (0.53) PTPRAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL7655431 0.70 EPHX1 (0.58) PTGS1SMN1; SMN2
SCHEMBL2187235 0.70 PTPRA (0.59) PTPRAGRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1472226-A1 HETEROCYCLIC AMIDE COMPOUNDS AS APOLIPOPROTEIN B INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-03 EP disclosed
WO-2004039795-A2 AMIDE COMPOUNDS FOR THE TREATMENT OF HYPERLIPIDEMIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-05-13 WO disclosed
EP-1326835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-16 EP disclosed
WO-2003045921-A1 HETEROCYCLIC AMIDE COMPOUNDS AS APOLIPOPROTEIN B INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-05 WO disclosed
WO-2002028835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-11 WO disclosed